Processing

Please wait...

Settings

Settings

Goto Application

1. US20040009245 - Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

[ EN ]

What is claimed is:

1. A method to reduce the risks of infection of the human respiratory system by pathogens causing Severe Acute Respiratory Syndrome (SARS) in an enclosed public area having one or more human beings within said public area comprising the following steps:
(a) within a period of time of 30 minutes before entering said public area, inhaling an effective amount of the concentrated vapors from Eucalyptus globulus; and
(b) after entering said public area, periodically inhaling the concentrated vapors from Eucalyptus globulus, whereby the period of time between successive inhalations exceeds 30 minutes, and whereby the period of time between successive inhalations is less than 2 hours.
2. The method in claim 1 whereby said pathogens include at least one strain of a coronavirus.
3. The method in claim 1 whereby said pathogens include at least one strain of a paramyxovirus.
4. The method in claim 1 whereby said pathogens include at least one strain of a coronavirus in association with at least a selected one of a strain of paramyxovirus and a strain of chlamydia bacteria.
5. A method to reduce the risks of infection of the human respiratory system by pathogens causing Severe Acute Respiratory Syndrome (SARS) in an enclosed public area having one or more human beings within said public area comprising the following steps:
(a) within a period of time of 30 minutes before entering said public area, inhaling an effective amount of the concentrated vapors from an essential oil that possesses antiseptic properties,
whereby said vapors are safe for human inhalation, and
whereby said antiseptic properties include selected antiviral, selected antibacterial, and selected antifungal properties; and
(b) after entering said public area, periodically inhaling the concentrated vapors from said essential oil, whereby the period of time between successive inhalations exceeds 30 minutes, and whereby the period of time between successive inhalations is less than 2 hours.
6. The method in claim 5 whereby said pathogens include at least one variety of coronavirus.
7. The method in claim 5 whereby said pathogens include at least one variety of paramyxovirus.
8. The method in claim 5 whereby said pathogens include at least one variety of coronavirus in association with at least a selected one of a variety of paramyxovirus and variety of chlamydia bacteria.
9. The method in claim 5 whereby the essential oil is selected to be one or more from the following list of essential oils: Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and Eucalyptus radiata.
10. A method to reduce the risks of infection of the human respiratory system by unknown respiratory pathogens in an enclosed public area having one or more human beings within said public area comprising the following steps:
(a) within a period of time of 30 minutes before entering said public area, inhaling the concentrated vapors from an essential oil that possesses antiseptic properties,
whereby said vapors are safe for human inhalation, and
whereby said antiseptic properties include selected antiviral, selected antibacterial, and selected antifungal properties, and
whereby the concentrated vapors from said essential oil are inhaled from a hand-held inhaler apparatus; and
(b) after entering said public area, periodically inhaling the concentrated vapors from said essential oil, whereby the period of time between successive inhalations exceeds 30 minutes, and whereby the period of time between successive inhalations is less than 2 hours.
11. The method in claim 10 whereby said unknown respiratory pathogens include the pathogen causing Severe Acute Respiratory Syndrome (SARS).
12. The method in claim 10 whereby said unknown pathogens include a variety of an influenza virus causing a flu.
13. The method in claim 10 whereby said unknown pathogens include a variety of a rhinovirus causing a cold.
14. The method in claim 10 whereby said unknown pathogens include a variety of the bacterium Staphylococcus aureus that causes staphylococcal pneumonia.
15. The method in claim 10 whereby said unknown pathogens include a variety of the bacterium Mycobacterium tuberculosis that causes tuberculosis.
16. The method in claim 10 whereby said unknown pathogens include a variety of the fungus Blastomyces dermatitidis that causes a fungal pneumonia.
17. The method in claim 10 whereby the essential oil is selected to be one or more from the following list of essential oils: Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and Eucalyptus radiata.
18. A method to prevent the infection of the human respiratory system by unknown pathogens that includes at least the step of inhaling the concentrated vapors from an essential oil having antiseptic properties, whereby said vapors are safe to inhale, and whereby said antiseptic properties include selected antibacterial properties, selected antiviral properties, and selected antifungal properties.
19. A method to treat the infection of the human respiratory system by pathogens causing Severe Acute Respiratory Syndrome (SARS) that includes at least the step of the inhalation of an effective amount of concentrated from an essential oil having antiseptic properties, whereby said vapors are safe to inhale, and whereby said antiseptic properties include selected antibacterial properties, selected antiviral properties, and selected antifungal properties.
20. The method in claim 19 whereby said essential oil is comprised of at least a selected one of Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and Eucalyptus radiata.
21. The method in claim 19 whereby said essential oil is comprised of a mixture of one or more of Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and Eucalyptus radiata.
22. A method to treat the infection of the human respiratory system by unknown pathogens that includes at least the step of inhaling concentrated vapors from an essential oil having antiseptic properties, whereby said vapors are safe to inhale, and whereby said antiseptic properties include selected antibacterial properties, selected antiviral properties, and selected antifungal properties.
23. A method to treat the infection of the human respiratory system by pathogens causing Severe Acute Respiratory Syndrome (SARS) that includes at least the step of the inhalation of an effective amount of concentrated vapors from any substance having antiseptic properties, whereby said vapors are safe to inhale, and whereby said antiseptic properties include selected antibacterial properties, selected antiviral properties, and selected antifungal properties.